Briefly about Biotech-IgG Equity AB (publ) Biotech-IgG Equity AB (publ) is a public investment company focusing on the Biotech sector and primarily conducts trade and distribution of hospital products in Sweden, Norway, Denmark, Finland, Iceland and Åland. The company has approximately 3,000 shareholders and the main owner today is the investment company Capital Conquest AB (publ).
View Top Employees from Biotech-IgG AB| Website | http://www.biotech-igg.com |
| Revenue | $560000 |
| Employees | View employees |
| Founded | 1989 |
| Address | Box 4211, Solna, Stockholm 171 04, SE |
| Phone | (465) 415-0410 |
| Fax | (464) 612-3740 |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Health Diagnostics, Health Care, Manufacturing |
| Competitors | Biozol GmbH, Diagnostic Technology, Filgen, Inc., Neuromics, Sapphire Bioscience Pty. Ltd. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Biotech-IgG AB employee's phone or email?
Biotech-IgG AB Questions
The Biotech-IgG AB annual revenue was $560000 in 2024.
Biotech-IgG AB is based in Solna, Stockholm.
The NAICS codes for Biotech-IgG AB are [54, 54171, 541713, 5417, 541].
The SIC codes for Biotech-IgG AB are [87, 873].
